Results 1 to 10 of about 1,968,036 (106)

Anti-HMGCR myopathy: a first case report from North Africa and literature insights [PDF]

open access: yesFrontiers in Immunology
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy is a rare idiopathic inflammatory myopathy characterized by severe muscle damage and minimal extra-muscular involvement.
Houssem Abida   +25 more
doaj   +4 more sources

Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model

open access: yesBiomedicines, 2022
Introduction: immune-mediated necrotising myopathy (IMNM) is associated with pathogenic anti-signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) antibodies, at least partly through activation of the classical pathway of ...
Sarah Julien   +13 more
doaj   +4 more sources

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy

open access: yesScientific Reports
Anti-HMGCR-positive immune-mediated necrotizing myopathy (IMNM), also anti-HMGCR myopathy, was initially considered as an exclusively skeletal muscular disease, observed in elderly patients with an acute onset.
Yuyan Cao   +14 more
doaj   +3 more sources

Cutaneous involvement in anti-HMGCR positive necrotizing myopathy [PDF]

open access: yesJournal of Autoimmunity, 2021
OBJECTIVE Anti-3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) positive immune-mediated necrotizing myopathy (IMNM) is a rare disease. It is induced by exogenous substances, most often by statins. Little is known about cutaneous manifestations
Laurence Feldmeyer   +2 more
exaly   +3 more sources

Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report

open access: yesSAGE Open Medical Case Reports, 2020
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) immune-mediated necrotizing myopathy is a subtype of idiopathic inflammatory myopathy which may be associated with statin exposure.
Darosa Lim   +6 more
doaj   +2 more sources

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

open access: yesArthritis Research & Therapy, 2020
Objective To describe successful therapeutic strategies in statin-induced anti-HMGCR myopathy. Methods Retrospective data from a cohort of 55 patients with statin-induced anti-HMGCR myopathy, sequentially stratified by the presence of proximal weakness ...
Alain Meyer   +33 more
doaj   +2 more sources

Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy [PDF]

open access: yesOpen Medicine
Statin use can lead to various muscle-related issues, including benign creatine kinase (CK) elevations, myalgias, toxic myopathies, rhabdomyolysis, and immune-mediated necrotizing myositis (IMNM), which primarily affects older males.
Braun Andreas Albert   +5 more
doaj   +2 more sources

Necrotising autoimmune myopathy

open access: yesAdvances in Clinical Neuroscience & Rehabilitation, 2017
Necrotising Autoimmune Myopathy is a subacute proximal myopathy with high creatine kinase levels and biopsy findings of necrotic and regenerating fibres with minimal inflammation.
Catherine Ashton, Merrilee Needham
doaj   +2 more sources

Dermatomyositis Like Presentation of Anti‐HMGCR Immune Mediated Necrotising Myopathy

open access: yesJEADV Clinical Practice
Extramuscular manifestations of anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) immune‐mediated necrotising myopathy (IMNM) are rare and often overlooked because they are overshadowed by predominant muscular symptoms.
Lionel Leblanc   +4 more
doaj   +2 more sources

Diagnostic and Therapeutic Challenges in Statin‐Induced Necrotizing Autoimmune Myopathy in an Elderly Patient: A Rare Case Report

open access: yesClinical Case Reports
We present the case of a 78‐year‐old woman with metabolic syndrome and a history of multiple ischemic strokes who developed progressive symmetrical proximal muscle weakness, predominantly affecting the lower extremities, while on atorvastatin. Laboratory
Nischal Shrestha   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy